For more CE opportunities, please visit: www.pharmacytimes.org CHAPTER MEETING Pharmacy Times Continuing Education ™ Invites You To… The Rapidly Evolving Treatment Landscape for Hepatocellular Carcinoma February 18, 2020 • 6:00PM FACULTY Courtney C. Cavalieri, PharmD, BCOP, is a clinical oncology pharmacist at the Huntsman Cancer Institute at the University of Utah. She completed her Doctor of Pharmacy at Philadelphia College of Pharmacy, her PGY1 Pharmacy Practice residency at the University of Colorado Hospital, and her PGY2 Oncology Pharmacy residency at Memorial Sloan Kettering Cancer Center. Since completing her PGY2, she has worked at Huntsman in Salt Lake City. Dr. Cavalieri is a Board Certified Oncology Pharmacist and currently practices in an ambulatory clinic that cares for patients with gastrointestinal and thoracic malignancies, as well as those on investigational therapeutics. She has taught the gastrointestinal modules for the ASHP/ACCP BCOP Review and Recertification course since 2017. At Huntsman, she serves on the Patient Education committee, as well as the Protocol Review and Monitoring Committee for clinical trials. She is also an active member on the Chemotherapy Order Template committee for NCCN and on the Membership committee for the Utah Society of Health-System Pharmacists. Heritage Club at Bethpage • 99 Quaker Meeting House Road • Farmingdale, NY 11735 FACULTY Courtney C. Cavalieri, PharmD, BCOP Clinical Oncology Pharmacist Gastrointestinal and Thoracic Oncology Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah Faculty disclosures will be provided prior to the presentation. EDUCATIONAL OBJECTIVES • Identify characteristics, including risk factors, that would suggest a patient should be referred for potential evaluation for HCC • Describe the current drug classes that are used in the treatment of patients with advanced HCC and their placement in guidelines • Explain what therapies are currently being studied for the treatment of advanced HCC and their potential places in therapy • Develop monitoring plans for patients undergoing treatment for advanced HCC, including management of dosing recommendations, drug interactions, and adverse effects Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-19-226-L01-P. The activity is available for CE credit through June 23, 2020. Type of Activity: Application This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc.; Eisai Inc.; Exelixis, Inc.; and Merck Sharp & Dohme Corp.

Continuing Education Invites You To…€¦ · Continuing Education ™ Invites You To… The Rapidly Evolving Treatment Landscape for Hepatocellular Carcinoma. February 18, 2020

Download PDF Report

Upload
others
View
2
Download
0

Embed Size (px)

Citation preview

Page 1: Continuing Education Invites You To…€¦ · Continuing Education ™ Invites You To… The Rapidly Evolving Treatment Landscape for Hepatocellular Carcinoma. February 18, 2020

For more CE opportunities, please visit:www.pharmacytimes.org

CHAPTERM E E T I N G

Pharmacy Times Continuing Education™

Invites You To…The Rapidly Evolving Treatment Landscape for Hepatocellular CarcinomaFebruary 18, 2020 • 6:00pm

FACULTY Courtney C. Cavalieri, PharmD, BCOP, is a clinical oncology pharmacist at the Huntsman Cancer Institute at the University of Utah. She completed her Doctor of Pharmacy at Philadelphia College of Pharmacy, her PGY1 Pharmacy Practice residency at the University of Colorado

Hospital, and her PGY2 Oncology Pharmacy residency at Memorial Sloan Kettering Cancer Center. Since completing her PGY2, she has worked at Huntsman in Salt Lake City. Dr. Cavalieri is a Board Certified Oncology Pharmacist and currently practices in an ambulatory clinic that cares for patients with gastrointestinal and thoracic malignancies, as well as those on investigational therapeutics. She has taught the gastrointestinal modules for the ASHP/ACCP BCOP Review and Recertification course since 2017. At Huntsman, she serves on the Patient Education committee, as well as the Protocol Review and Monitoring Committee for clinical trials. She is also an active member on the Chemotherapy Order Template committee for NCCN and on the Membership committee for the Utah Society of Health-System Pharmacists.

Heritage Club at Bethpage • 99 Quaker Meeting House Road • Farmingdale, NY 11735

FACULTY

Courtney C. Cavalieri, PharmD, BCOPClinical Oncology PharmacistGastrointestinal and Thoracic OncologyHuntsman Cancer Institute at the University of UtahSalt Lake City, Utah

Faculty disclosures will be provided prior to the presentation.

EDUCATIONAL OBJECTIVES

• Identify characteristics, including risk factors, that would suggest a patientshould be referred for potential evaluation for HCC

• Describe the current drug classes that are used in the treatment ofpatients with advanced HCC and their placement in guidelines

• Explain what therapies are currently being studied for the treatment ofadvanced HCC and their potential places in therapy

• Develop monitoring plans for patients undergoing treatment foradvanced HCC, including management of dosing recommendations, druginteractions, and adverse effects

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-19-226-L01-P. The activity is available for CE credit through June 23, 2020.

Type of Activity: Application

This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc.; Eisai Inc.; Exelixis, Inc.; and Merck Sharp & Dohme Corp.